The Rapid Diagnostic Kits Market for Indian Ocean Region Countries is expected to register a CAGR of 1.6% from 2022 to 2029 to reach $1.75 billion by 2029. The rapid diagnostics kits market for Indian Ocean region countries covers professional kits and OTC kits offered by key companies in the market to hospitals, clinical laboratories, and home care settings for the qualitative and quantitative detection of specific antigens, antibodies, genetic material, or proteins associated with a particular health condition or disease, helping uncover the underlying mechanisms of diseases and enabling doctors and healthcare workers to make crucial medical decisions. These test kits provide diagnostic results expeditiously (within 1 hour). For the scope of this report, the Indian Ocean region countries include France, India, Australia, Singapore, Indonesia, Madagascar, Mauritius, Réunion, Comoros, Mayotte, and Seychelles.
The growth of this market is driven by the growing demand for PoC diagnostics, the high prevalence of chronic diseases coupled with the increasing geriatric population, the growing prevalence of infectious diseases, the increasing need for rapid decision-making, and the outbreak of the COVID-19 pandemic. Moreover, emerging markets are expected to offer growth opportunities for the players operating in the rapid diagnostic kits market in Indian Ocean region countries. However, variance in test results is a restraining factor for the growth of this market. Additionally, the reluctance to change the existing diagnostic practices is a major challenge for market growth.
Diagnostic tests play a crucial role in the medical care of patients with infections. Usual methods for detecting specific pathogens are generally time-consuming and expensive and require complex analytical instruments and skilled technicians. Also, rapid diagnostic tests are in demand as they can diagnose infectious diseases early, which helps prevent their spread. Rapid diagnostic kits for diagnosing infectious diseases are in high demand in the in-vitro diagnostics (IVD) industry due to the increasing awareness regarding infectious diseases in developing countries, expanding test menus, and advancements in molecular testing and lab-on-chip technology. As the demand for rapid diagnostic kits increases, manufacturing companies compete to develop next-generation rapid diagnostics platforms that are faster, easier to use, and more reliable.
In recent years, the incidence of infectious diseases has increased considerably. For instance, In India, every year, 30 million new cases of sexually transmitted diseases (STDs) and reproductive tract infections (RTIs) are reported. Also, the prevalence of HIV in the population aged 15–49 years is 0.2%. Although the prevalence rate is extremely low, it translates to 2.1 million people due to India’s high population. In addition to this, Indonesia has a high prevalence of tuberculosis. According to the WHO, in 2020, Indonesia accounted for 8.4% of all estimated tuberculosis cases globally. Hence, the growing incidence of infectious diseases further boosted the demand for rapid diagnostic kits to diagnose and manage various infectious diseases. Therefore, looking at the overall scenario, the growing prevalence of infectious diseases is estimated to drive the growth of the rapid diagnostic kits market in Indian Ocean region countries.
Click here to: Get Free Request Sample Pages of this report
Professional Kits Generated Larger Proportion of Revenue Compared to OTC Kits in 2022
The professional kits segment is expected to account for the larger share of the rapid diagnostic kits market in Indian Ocean region countries in 2022. The large market share of this segment is attributed to the availability of disease-specific assays for the early diagnosis of chronic diseases, technological advancements in rapid diagnostics, and the high awareness of professional rapid diagnostic kits.
Immunoassays to Dominate the Market
The immunoassays segment is expected to account for the largest share of the rapid diagnostic kits market in Indian Ocean region countries in 2022. The large market share of this segment is mainly attributed to the high prevalence of chronic and infectious diseases, technological innovations, and the advantages of rapid immunoassay tests, such as cost-effectiveness and at-home testing.
Infectious Diseases Segment to Register Largest Share in the Rapid Diagnostics Kits Market for Indian Ocean Region Countries in 2022
The infectious diseases testing segment is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries in 2022. The high prevalence of target diseases and outbreaks of infectious diseases and the rise in the awareness and adoption of self-testing kits for infectious diseases are supporting the large market share of this segment.
Hospital & Clinics Segment to Dominate the Market in 2022
The hospital & clinics segment is expected to account for the largest share of the rapid diagnostic kits market in Indian Ocean region countries in 2022. The high rate of hospitalizations due to various diseases, the rising geriatric population, and increased healthcare access & expenditure are the primary factors contributing to the largest share of the market.
India: Fastest Growing Geography
India is expected to be the fastest-growing country during the forecast period. Factors driving the growth of this country include the rising prevalence of chronic diseases and initiatives taken by the government to promote health awareness in the country. According to National AIDS Control Organisation (NACO), around 6% of the adult population (around 30 million people) in India is diagnosed with reproductive tract infections (RTIs) each year, including sexually transmitted infections (STIs). As rapid diagnostics can facilitate accurate and quick diagnosis and management of diseases, the demand for rapid diagnostic kits in India is expected to grow exponentially in the coming years.
In recent years, government initiatives have increased to promote health awareness in the country. Pradhan Mantri Jan Arogya Yojana, Ayushman Bharat, and Mission Indradhanush are some of the recent initiatives launched by the Government of India to promote health awareness. These initiatives are expected to boost the demand for rapid diagnostic kits leading to the growth of this market.
Key Players
The report includes a competitive landscape based on an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3 years. The key players profiled in the rapid diagnostic kits market for Indian Ocean region countries report include Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).
Scope of the Report
Rapid Diagnostic Kits Market for Indian Ocean Region Countries, by Product
Rapid Diagnostic Kits Market for Indian Ocean Region Countries, by Platform
Rapid Diagnostic Kits Market for Indian Ocean Region Countries, by Application
Rapid Diagnostic Kits Market for Indian Ocean Region Countries, by End User
Rapid Diagnostic Kits Market for Indian Ocean Region Countries, by Geography
Key questions answered in the report:
This report provides an analysis of the rapid diagnostic kits market in Indian Ocean region countries (France, India, Australia, Singapore, Indonesia, Madagascar, Mauritius, Réunion, Comoros, Mayotte, and Seychelles), covering platforms such as immunoassays and molecular detection used for applications such as blood glucose testing, cardiac metabolism testing, infectious diseases testing, coagulation testing, pregnancy & fertility testing, fecal occult testing, hematology testing, tumor/cancer markers testing, drugs of abuse testing, cholesterol testing, and urinalysis. The rapid diagnostics kits covered in this report provide diagnostic results expeditiously (within 1 hour).
The rapid diagnostics kits market for Indian Ocean region countries is projected to reach $1.75 billion by 2029, at a CAGR of 1.6% during the forecast period.
Based on product, the OTC kits segment is expected to show the fastest growth rate in the forecast period. The growth of this segment can be attributed to the rising demand for at-home testing, growing awareness about self-testing among the general population, and the increasing prevalence of diseases that require rapid and effective testing. OTC kits are generally at-home testing kits used for fertility testing, blood glucose monitoring, cholesterol testing, and infectious and chronic disease testing. The home testing kits allow patients to save the time and money required for hospital/lab visits, as these tests can be performed at home, and results can be shared with physicians remotely.
The immunoassays segment is expected to account for the largest share of the rapid diagnostic kits market in Indian Ocean region countries in 2022. Immunoassay-based diagnostic kits are widely used in hospitals, clinical laboratories, and home care for the qualitative and quantitative diagnosis and management of communicable and non-communicable diseases. These are commonly used due to their advantages, such as their one-step process, long shelf life, higher portability & lower costs compared to conventional laboratory-based tests, low sample quantities required for testing, recent technological developments, and the increasing use of lateral flow assay kits that can be used at home. The large market share of this segment is mainly attributed to the growing prevalence of chronic and infectious diseases, technological innovations, and the advantages of rapid immunoassay tests, such as cost-effectiveness and at-home testing.
The tumor/cancer markers testing segment is expected to show the fastest growth rate during the forecast period. The burden of cancer is growing, exerting tremendous economic strain on countries. Nearly 70% of cancer deaths occur in low and middle-income countries (source: WHO). The burden of cancer is large in India, Australia, Singapore, Indonesia, Madagascar, Mauritius, Réunion, Comoros, Mayotte, and Seychelles; for example, in 2020, India reported 1,324,413 new cancer cases and this number is projected to reach 1,692,968 by 2030(source: GLOBOCAN). Furthermore, France reported 467,965 new cancer cases and this number is projected to reach 530,863 by 2030 (source: GLOBOCAN). Early detection is very important in reducing mortality, improving the chances of survival, and saving on treatment costs. Various rapid diagnostic kits are used to detect cancer. It is estimated that the demand for rapid diagnostic kits that support cancer testing will grow significantly in the coming years.
The hospitals & clinics segment is expected to account for the largest share of the rapid diagnostic kits market in Indian Ocean region countries in 2022. Factors attributing to this segment's growth include the rising number of hospitalizations due to various diseases, the increasing geriatric population, and rising healthcare access & expenditure. Hospitals & clinics perform a wide range of tests to diagnose various medical conditions to ensure proper clinical planning of treatment and prevention. The growing demand for point-of-care diagnostics, increasing healthcare expenditure, rising prevalence of healthcare-associated infections (HAIs), and growing number of hospitals and clinics across emerging markets are driving the demand for rapid diagnostic kits used in hospitals & clinics.
The growth of this market is driven by the growing demand for PoC diagnostics, the high prevalence of chronic diseases coupled with the increasing geriatric population, the growing prevalence of infectious diseases, the increasing need for rapid decision-making, and the outbreak of the COVID-19 pandemic. Moreover, emerging countries are expected to offer growth opportunities for the players operating in the rapid diagnostic kits market in Indian Ocean region countries.
Key companies operating in the rapid diagnostic kits market for Indian Ocean region countries are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.4. Assumptions for this Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population
4.2.2. Growing Prevalence of Infectious Diseases
4.2.3. Increasing Need for Rapid Decision-making & Growing Demand for Point-of-Care (POC) Diagnostics
4.2.4. The Outbreak of the COVID-19 Pandemic
4.3. Restraints
4.3.1. Variance in Test Results
4.4. Opportunities
4.4.1. Untapped Potential in Emerging Economies of the Countries in the Indian Ocean Region
4.5. Challenges
4.5.1. Reluctance toward Changing Existing Diagnostic Practices
4.6. Rapid Diagnostics: Innovations & Upcoming Technologies
5. Rapid Diagnostic Kits Market in Indian Ocean Region Countries, by Product
5.1. Introduction
5.2. Professional Kits
5.3. OTC Kits
6. Rapid Diagnostic Kits Market in Indian Ocean Region Countries, by Platform
6.1. Introduction
6.2. Immunoassays
6.3. Molecular Detection Tests
6.4. Other Rapid Diagnostic Platforms
7. Rapid Diagnostic Kits Market for Indian Ocean Region Countries, by Application
7.1. Introduction
7.2. Infectious Diseases Testing
7.3. Pregnancy & Fertility Testing
7.4. Cardiac Metabolism Testing
7.5. Cholesterol Testing
7.6. Tumor/Cancer Markers Testing
7.7. Blood Glucose Testing
7.8. Urinalysis
7.9. Hematology Testing
7.10. Other Tests
8. Rapid Diagnostic Kits Market for Indian Ocean Region Countries, by End User
8.1. Introduction
8.2. Hospital & Clinics
8.3. Diagnostic Laboratories
8.4. Home Care/Self-testing
8.5. Other End Users
9. Rapid Diagnostic Kits Market in Indian Ocean Region Countries, by Geography
9.1. Introduction
9.2. France
9.3. India
9.4. Australia
9.5. Indonesia
9.6. Singapore
9.7. Sri Lanka
9.8. Madagascar
9.9. Mauritius
9.10. Réunion
9.11. Mayotte
9.12. Seychelles
9.13. Comoros
10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)
11.1. Abbott Laboratories (U.S.)
11.2. Becton, Dickinson and Company (BD) (U.S.)
11.3. Bio-Rad Laboratories, Inc. (U.S.)
11.4. F. Hoffmann-La Roche Ltd (Switzerland)
11.5. ACON Laboratories, Inc. (U.S.)
11.6. Danaher Corporation (U.S.)
11.7. Thermo Fisher Scientific Inc. (U.S.)
11.8. bioMérieux S.A. (France)
11.9. Alfa Scientific Designs, Inc. (U.S.)
11.10. BTNX Inc. (Canada)
11.11. Meridian Bioscience, Inc. (U.S.)
11.12. Trinity Biotech plc (Ireland)
12. Appendix
12.1. Questionnaire
List of Tables
Table 1 Rapid Diagnostic Kits Market for Indian Ocean Region Countries: Impact Analysis of Market Drivers (2022–2029)
Table 2 Estimated Number of New Cancer Cases, by Country (2020 VS. 2030)
Table 3 Number of People Living with Diabetes, by Country (2011 VS. 2021 VS. 2030)
Table 4 Number of People Aged 65 Years and Above, by Country, 2019 VS. 2030
Table 5 Adults and Children Living with HIV, by Country (2021)
Table 6 Prevalence of COVID-19, by Country
Table 7 Rapid Diagnostic Kits Market for Indian Ocean Region Countries: Impact Analysis of Market Restraints (2022–2029)
Table 8 GDP Per Capita of Some of the Countries in the Indian Ocean Region
Table 9 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries, by Product, 2020–2029 (USD Million)
Table 10 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries for Professional Kits, by Country/Region, 2020–2029 (USD Million)
Table 11 No. of People with Diabetes in Some of the Indian Ocean Region Countries (2021)
Table 12 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries for OTC Kits, by Country/Region, 2020–2029 (USD Million)
Table 13 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries, by Platform, 2020–2029 (USD Million)
Table 14 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries for Immunoassays, by Country/Region, 2020–2029 (USD Million)
Table 15 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries Molecular Detection Tests, by Country/Region, 2020–2029 (USD Million)
Table 16 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries for Other Rapid Diagnostic Platforms, by Country/Region, 2020–2029 (USD Million)
Table 17 Rapid Diagnostic Kits Market for Indian Ocean Region Countries Size, by Application, 2020–2029 (USD Million)
Table 18 Rapid Diagnostic Kits Market Size for Infectious Disease Testing, by Country/Region, 2020–2029 (USD Million)
Table 19 Rapid Diagnostic Kits Market Size for Pregnancy & Fertility Testing, by Country/Region, 2020–2029 (USD Million)
Table 20 Deaths From Cardiovascular Diseases in Singapore (2019–2021)
Table 21 Rapid Diagnostic Kits Market Size for Cardiac Metabolism Testing, by Country/Region, 2020–2029 (USD Million)
Table 22 Rapid Diagnostic Kits Market Size for Cholesterol Testing, by Country/Region, 2020–2029 (USD Million)
Table 23 Rapid Diagnostic Kits Market Size for Tumor/Cancer Testing, by Country/Region, 2020–2029 (USD Million)
Table 24 Number of People with Diabetes in Some of the Indian Ocean Region Countries (2021)
Table 25 Rapid Diagnostic Kits Market Size for Blood Glucose Testing, by Country/Region, 2020–2029 (USD Million)
Table 26 Rapid Diagnostic Kits Market Size for Urinalysis, by Country/Region, 2020–2029 (USD Million)
Table 27 Anemia Prevalence India (2014–2015 VS. 2019–2021)
Table 28 Rapid Diagnostic Kits Market Size for Hematology, by Country/Region, 2020–2029 (USD Million)
Table 29 Rapid Diagnostic Kits Market Size for Other Tests, by Country/Region, 2020–2029 (USD Million)
Table 30 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by End User, 2020–2029 (USD Million)
Table 31 Rapid Diagnostic Kits Market Size for Hospitals & Clinics, by Country/Region, 2020–2029 (USD Million)
Table 32 Rapid Diagnostic Kits Market Size for Diagnostic Laboratories, by Country/Region, 2020–2029 (USD Million)
Table 33 Population Aged 65 and Above, Total Number (2021)
Table 34 Rapid Diagnostic Kits Market Size for Home Care/Self-testing, by Country/Region, 2020–2029 (USD Million)
Table 35 Rapid Diagnostic Kits Market Size for Other End Users, by Country/Region, 2020–2029 (USD Million)
Table 36 Rapid Diagnostic Kits Market in Indian Ocean Region Countries Size, by Country, 2020–2029 (USD Million)
Table 37 France: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 38 France: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 39 France: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 40 France: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 41 Recent Initiatives Launched by the Government of India to Combat the COVID–19 Pandemic
Table 42 India: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 43 India: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 44 India: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 45 India: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 46 Australia: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 47 Australia: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 48 Australia: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 49 Australia: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 50 Indonesia: Tuberculosis Statistics
Table 51 Indonesia: HIV Statistics (2021)
Table 52 Indonesia: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 53 Indonesia: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 54 Indonesia: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 55 Indonesia: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 56 Singapore: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 57 Singapore: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 58 Singapore: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 59 Singapore: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 60 Sri Lanka: Leading Causes of Hospital Deaths (2019)
Table 61 Sri Lanka: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 62 Sri Lanka: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 63 Sri Lanka: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 64 Sri Lanka: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 65 Madagascar: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million)
Table 66 Madagascar: Rapid Diagnostic Kits Market Size, by Platform, 2020–2029 (USD Million)
Table 67 Madagascar: Rapid Diagnostic Kits Market Size, by Application, 2020–2029 (USD Million)
Table 68 Madagascar: Rapid Diagnostic Kits Market Size, by End User, 2020–2029 (USD Million)
Table 69 Mauritius: Leading Causes of Death
Table 70 Recent Developments, by Company, 2019–2022
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Product, 2022 VS. 2029 (USD Million)
Figure 8 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Platform, 2022 VS. 2029 (USD Million)
Figure 9 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Application, 2022 VS. 2029 (USD Million)
Figure 10 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by End User, 2022 VS. 2029 (USD Million)
Figure 11 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Country, 2022 VS. 2029
Figure 12 Market Dynamics
Figure 13 Rapid Diagnostic Kits Market in Indian Ocean Region Countries, by Product, 2022 VS. 2029 (USD Million)
Figure 14 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries, by Platform, 2022 VS. 2029 (USD Million)
Figure 15 Rapid Diagnostic Kits Market for Indian Ocean Region Countries Size, by Application, 2022 VS. 2029 (USD Million)
Figure 16 Deaths Due to Heart Attacks in India (2017–2020)
Figure 17 Estimated Number of New Cancer Cases in Some of the Countries of the Indian Ocean Region, 2020–2030
Figure 18 Prevalence of Impaired Glucose Tolerance in India & Indonesia (2019–2045) (Million)
Figure 19 Estimated Number of New Leukemia Cases in Some of the Countries in the Indian Ocean Region (2020–2030)
Figure 20 Estimated Number of New Colon Cancer Cases in Some of the Indian Ocean Region Countries (2020 VS. 2030)
Figure 21 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by End User, 2022–2029 (USD Million)
Figure 22 Healthcare Expenditure Per Capita, Purchasing Power Parities (PPP), (USD), 2019
Figure 23 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries, by Country, 2022–2029 (USD Million)
Figure 24 France: Percentage of Population Aged 65 Years and Above, 2016–2020
Figure 25 France: Prevalence of Chronic Diseases in People Aged 65 and Above (2019)
Figure 26 France: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 27 India: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 28 Australia: Most Prevalent Chronic Diseases (2020–2021) (% of Total Population)
Figure 29 Australia: Infectious Disease Cases, in Thousand (2017–2021)
Figure 30 Australia: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 31 Indonesia: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 32 Singapore: Number of Deaths Due to Diseases (% of Total Population) (2019–2020)
Figure 33 Singapore: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 34 Sri Lanka: Government Health Expenditure (2017–2019)
Figure 35 Sri Lanka: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 36 Madagascar: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 37 Mauritius: Deaths Per 100,000 People Due to Ncd (2017–2020)
Figure 38 Mauritius: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 39 Réunion: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 40 Mayoytte: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 41 Seychelles: Number of People Aged 65 Years and Above
Figure 42 Seychelles: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 43 Comoros: Number of People Aged 65 Years and Above (2015–2021)
Figure 44 Comoros: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 45 Key Growth Strategies Adopted by Leading Players (2019–2022)
Figure 46 Rapid Diagnostic Kits Market for Indian Ocean Region Countries: Competitive Benchmarking, by Platform
Figure 47 Abbott Laboratories: Financial Overview (2021)
Figure 48 Becton, Dickinson and Company: Financial Overview (2021)
Figure 49 Bio-Rad Laboratories, Inc.: Financial Overview (2021)
Figure 50 F. Hoffmann-La Roche Ltd: Financial Overview (2021)
Figure 51 Danaher Corporation: Financial Overview (2021)
Figure 52 Thermo Fisher Scientific Inc.: Financial Overview (2021)
Figure 53 bioMérieux S.A.: Financial Overview (2021)
Figure 54 Meridian Bioscience, Inc.: Financial Overview (2021)
Figure 55 Trinity Biotech plc: Financial Overview (2021)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Nov-2023
Published Date: Oct-2023
Published Date: Feb-2023
